Endurance Wealth Management, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 1,954 shares of MIRM stock, worth $65,810. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,954
Previous 1,954
-0.0%
Holding current value
$65,810
Previous $47,000
6.38%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$219 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$147 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$111 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$95.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$93.2 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.24B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...